Corrigendum: The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

Ming-Hsien Tsai,Mingchih Chen,Yen-Chun Huang,Hung-Hsiang Liou,Yu-Wei Fang

DOI: https://doi.org/10.3389/fphar.2022.894462

IF: 5.6

2022-03-31

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2019.00079.].

pharmacology & pharmacy

What problem does this paper attempt to address?

Correction: Aliskiren Therapy in Hypertension and Cardiovascular Disease: a Systematic Review and a Meta-Analysis

Shufang Fu,Xin Wen,Fei Han,Longwei Yin,Gaosi Xu

DOI: https://doi.org/10.18632/oncotarget.24255

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.19382.].
Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Lanlan Xiao,Xingqi Xu,Kaizhou Huang,Yalei Zhao,Lingjian Zhang,Lanjuan Li

DOI: https://doi.org/10.1155/2021/9875940

2021-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2019/3757149.].
Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Hangying Ying,Hongdi Yuan,Xiaomei Tang,Wenpu Guo,Ruhong Jiang,Chenyang Jiang

DOI: https://doi.org/10.3389/fcvm.2021.723626

IF: 3.6

2021-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.641062.].
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Corrigendum: Tooth loss, denture use, and all-cause and cause-specific mortality in older adults: a community cohort study

Miao Dai,Quhong Song,Taiping Lin,Xiaohong Huang,Yufang Xie,Xiang Wang,Liwei Zheng,Jirong Yue

DOI: https://doi.org/10.3389/fpubh.2023.1360927

IF: 5.2

2024-01-09

Frontiers in Public Health

Abstract:[This corrects the article DOI: 10.3389/fpubh.2023.1194054.].

public, environmental & occupational health
Corrigendum: Reduced serum calcium is associated with a higher risk of retinopathy in non-diabetic individuals: The Chinese Multi-provincial Cohort Study

Jiangtao Li,Dong Zhao,Qiuju Deng,Yongchen Hao,Miao Wang,Jiayi Sun,Jun Liu,Guandi Ren,Huiqi Li,Yue Qi,Jing Liu

DOI: https://doi.org/10.3389/fendo.2022.1114158

IF: 6.055

2022-12-21

Frontiers in Endocrinology

Abstract:[This corrects the article DOI: 10.3389/fendo.2022.973078.].

endocrinology & metabolism
Corrigendum: Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: a cross-sectional study

Xiaojing Yin,Fan Zhang,Yan Shi

DOI: https://doi.org/10.3389/fmed.2023.1217890

IF: 3.9

2023-06-29

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2023.1142013.].

medicine, general & internal
Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study

Yusi Chen,Jun Luo,Jingyuan Chen,Eugene Kotlyar,Zilu Li,Wenjie Chen,Jiang Li

DOI: https://doi.org/10.3389/fphar.2022.891907

IF: 5.6

2022-04-11

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.811700.].

pharmacology & pharmacy
Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury

Jiajia Li,Yupeng Jiang,Qin Dai,Yue Yu,Xin Lv,Yan Zhang,Xiaohua Liao,Liyun Ao,Gaoyun Hu,Jie Meng,Zhangzhe Peng,Lijian Tao,Yanyun Xie

DOI: https://doi.org/10.3389/fphar.2023.1188615

IF: 5.6

2023-04-06

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1043945.].

pharmacology & pharmacy
Corrigendum: Systolic blood pressure as the mediator of the effect of early menarche on the risk of coronary artery disease: A Mendelian randomization study

Hsien Yu Fan,Yen-Tsung Huang,Yun-Yu Chen,Justin BOKAI HSU,Hung-Yuan Li,Ta-Chen Su,Hung-Ju Lin,Kuo-Liong Chien,Yang Ching Chen

DOI: https://doi.org/10.3389/fcvm.2023.1165387

IF: 3.6

2023-03-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2022.1023355.].

cardiac & cardiovascular systems
The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

Ming-Hsien Tsai,Mingchih Chen,Yen-Chun Huang,Hung-Hsiang Liou,Yu-Wei Fang

DOI: https://doi.org/10.3389/fphar.2021.804000

IF: 5.6

2022-01-28

Frontiers in Pharmacology

Abstract:Lipid-lowering agents display limited benefits on cardiovascular diseases and mortality in patients undergoing dialysis. Therefore, they are not routinely recommended for dialysis patients. The aim of this study was to assess the effects of lipid-lowering agents on clinical outcomes in dialysis patients on the basis of real-world evidence. This research used Taiwan’s National Health Insurance Research Database to identify dialysis patients from January 2009 to December 2015; patients were then categorized into a case group treated with lipid-lowering agents ( n = 3,933) and a control group without lipid-lowering agents ( n = 24,267). Patients were matched by age, sex, and comorbidities in a 1:1 ratio. This study used the Cox regression model to estimate the hazard ratios (HRs) for mortality and major adverse cardiovascular events (MACEs) for events recorded until December 2017. During a mean follow-up period of approximately 3.1 years, 1726 [43.9%, incidence 0.123/person-year (PY)] deaths and 598 (15.2%, incidence 0.047/PY) MACEs occurred in the case group and 2031 (51.6%, incidence 0.153/PY) deaths and 649 (16.5% incidence 0.055/PY) MACEs occurred in the control group. In the multivariable analysis of the Cox regression model, lipid-lowering agent users showed a significantly lower risk of death [HR: 0.75; 95% confidence interval (CI): 0.70–0.80] and MACEs (HR: 0.88; 95% CI: 0.78–0.98) than lipid-lowering agent non-users. Moreover, the survival benefit of lipid-lowering agents was significant across most subgroups. Dialysis patients treated with lipid-lowering agents display a 25 and 12% reduction in their risk of mortality and MACEs, respectively. Therefore, lipid-lowering agents might be considered when treating dialysis patients with hyperlipidemia.

pharmacology & pharmacy
Corrigendum: Long-term kidney prognosis and pathological characteristics of late-onset lupus nephritis

Na Tian,Qian Zhou,PeiRan Yin,WenFang Chen,LingYao Hong,QiMei Luo,MengHua Chen,XueQing Yu,Wei Chen

DOI: https://doi.org/10.3389/fmed.2022.1018311

IF: 3.9

2022-09-05

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2022.882692.].

medicine, general & internal
Correction to: Changes in frailty and incident cardiovascular disease in three prospective cohorts

DOI: https://doi.org/10.1093/eurheartj/ehae175

IF: 39.3

2024-03-30

European Heart Journal

Abstract:This is a correction to: Di He, Zhaoping Wang, Jun Li, Kaixin Yu, Yusa He, Xinyue He, Yuanjiao Liu, Yuhao Li, Ruiyi Fu, Dan Zhou, Yimin Zhu, Changes in frailty and incident cardiovascular disease in three prospective cohorts, European Heart Journal , 2024; https://doi.org/10.1093/eurheartj/ehad885

cardiac & cardiovascular systems
Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice

Yan-Mei Wang,Shou-Ling Mi,Hong Jin,Qi-Lin Guo,Zhong-Yu Yu,Jian-Tao Wang,Xiao-Ming Zhang,Qian Zhang,Na-Na Wang,Yan-Yan Huang,Hou-Guang Zhou,Jing-Chun Guo

DOI: https://doi.org/10.3389/fphar.2021.827490

IF: 5.6

2022-01-03

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.754387.].

pharmacology & pharmacy
Corrigendum to “sex Differences in HIV Treatment Outcomes and Adherence by Exposure Groups among Adults in Guangdong, China: A Retrospective Observational Cohort Study” [eclinicalmedicine 22 (2020) 100351]

Linghua Li,Tanwei Yuan,Junfeng Wang,Thomas Fitzpatrick,Quanmin Li,Peiyang Li,Xiaoping Tang,Guohong Xu,Dahui Chen,Bowen Liang,Weiping Cai,Huachun Zou

DOI: https://doi.org/10.1016/j.eclinm.2020.100618

IF: 15.1

2020-01-01

EClinicalMedicine

Abstract:[This corrects the article DOI: 10.1016/j.eclinm.2020.100351.].
Corrigendum: Association between lactate/albumin ratio and 28-day all-cause mortality in ischemic stroke patients without reperfusion therapy: a retrospective analysis of the MIMIC-IV database

Yuan Zhong,Hao Sun,Hongzhuang Chen,Wenjuan Jing,Weiqiang Chen,Junqiang Ma

DOI: https://doi.org/10.3389/fneur.2024.1501758

IF: 3.4

2024-10-16

Frontiers in Neurology

Abstract:This article is a correction to: Association between lactate/albumin ratio and 28-day all-cause mortality in ischemic stroke patients without reperfusion therapy: a retrospective analysis of the MIMIC-IV database

neurosciences,clinical neurology
Corrigendum: Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19

Huikuan Chu,Tao Bai,Liuying Chen,Lilin Hu,Li Xiao,Lin Yao,Rui Zhu,Xiaohui Niu,Zhonglin Li,Lei Zhang,Chaoqun Han,Shuangning Song,Qi He,Ying Zhao,Qingjing Zhu,Hua Chen,Bernd Schnabl,Ling Yang,Xiaohua Hou

DOI: https://doi.org/10.3389/fmed.2021.764493

IF: 3.9

2021-09-16

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2020.584342.].

medicine, general & internal
Corrigendum: Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Huifang Wang,Bin Liu,Ying Tang,Ping Chang,Lishuai Yao,Bo Huang,Robert F Lodato,Zhanguo Liu

DOI: https://doi.org/10.3389/fphar.2019.01697

2020-02-21

Abstract:[This corrects the article DOI: 10.3389/fphar.2019.01370.].
Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry

Hui-Wei Shi,Jin-Gang Yang,Yang Wang,Wei Li,Yuan-Lin Guo,Ying Gao,Yi-Da Tang,Jian-Jun Li,Na-Qiong Wu,Yue-Jin Yang

DOI: https://doi.org/10.3389/fcvm.2020.00160

IF: 3.6

2020-08-26

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2020.00113.].

cardiac & cardiovascular systems
Corrigendum: Non-alcoholic fatty liver disease is associated with aortic calcification: a cohort study with propensity score matching

Rong-Rong Zhu,Xu-Ping Gao,Min-Qi Liao,Yun-Feng Cui,Si-Xian Tan,Fang-Fang Zeng,Yan-Mei Lou,Chang-Yi Wang,Shan Xu,Xiao-Lin Peng,Shu-Hong Dai,Dan Zhao,Li Wang,Zhao Ping,Xiao-Yu Dai,Pin-Ning Feng,Li-Yuan Han

DOI: https://doi.org/10.3389/fendo.2023.1248377

IF: 6.055

2023-07-10

Frontiers in Endocrinology

Abstract:[This corrects the article DOI: 10.3389/fendo.2022.880683.].

endocrinology & metabolism

Corrigendum: The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

Correction: Aliskiren Therapy in Hypertension and Cardiovascular Disease: a Systematic Review and a Meta-Analysis

Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Corrigendum: Tooth loss, denture use, and all-cause and cause-specific mortality in older adults: a community cohort study

Corrigendum: Reduced serum calcium is associated with a higher risk of retinopathy in non-diabetic individuals: The Chinese Multi-provincial Cohort Study

Corrigendum: Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: a cross-sectional study

Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study

Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury

Corrigendum: Systolic blood pressure as the mediator of the effect of early menarche on the risk of coronary artery disease: A Mendelian randomization study

The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

Corrigendum: Long-term kidney prognosis and pathological characteristics of late-onset lupus nephritis

Correction to: Changes in frailty and incident cardiovascular disease in three prospective cohorts

Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice

Corrigendum to “sex Differences in HIV Treatment Outcomes and Adherence by Exposure Groups among Adults in Guangdong, China: A Retrospective Observational Cohort Study” [eclinicalmedicine 22 (2020) 100351]

Corrigendum: Association between lactate/albumin ratio and 28-day all-cause mortality in ischemic stroke patients without reperfusion therapy: a retrospective analysis of the MIMIC-IV database

Corrigendum: Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19

Corrigendum: Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry

Corrigendum: Non-alcoholic fatty liver disease is associated with aortic calcification: a cohort study with propensity score matching

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]